SI9520087A - USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA - Google Patents

USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA Download PDF

Info

Publication number
SI9520087A
SI9520087A SI9520087A SI9520087A SI9520087A SI 9520087 A SI9520087 A SI 9520087A SI 9520087 A SI9520087 A SI 9520087A SI 9520087 A SI9520087 A SI 9520087A SI 9520087 A SI9520087 A SI 9520087A
Authority
SI
Slovenia
Prior art keywords
same
adenosyl
methionine
physiologically compatible
compatible salts
Prior art date
Application number
SI9520087A
Other languages
English (en)
Slovenian (sl)
Inventor
Laszlo Szabo
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of SI9520087A publication Critical patent/SI9520087A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
SI9520087A 1994-07-16 1995-07-05 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA SI9520087A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4425280A DE4425280C2 (de) 1994-07-16 1994-07-16 Verwendung von (S)-Adenosyl-L-methionin und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die nach temporärer fokaler Ischämie ausgelöst werden

Publications (1)

Publication Number Publication Date
SI9520087A true SI9520087A (en) 1997-08-31

Family

ID=6523426

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9520087A SI9520087A (en) 1994-07-16 1995-07-05 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA

Country Status (18)

Country Link
US (1) US5776911A (de)
EP (1) EP0771202A1 (de)
JP (1) JPH10502652A (de)
KR (1) KR970704442A (de)
AU (1) AU2927195A (de)
BG (1) BG101145A (de)
CA (1) CA2195345A1 (de)
CZ (1) CZ12297A3 (de)
DE (1) DE4425280C2 (de)
FI (1) FI970165A (de)
HR (1) HRP950405A2 (de)
HU (1) HUT76834A (de)
IL (1) IL114540A0 (de)
NO (1) NO970185L (de)
PL (1) PL318318A1 (de)
SI (1) SI9520087A (de)
WO (1) WO1996002252A1 (de)
ZA (1) ZA955865B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
IT1317920B1 (it) * 2000-10-20 2003-07-15 Univ Roma S-adenosilmetionina e suoi derivati per il trattamento e laprevenzione della malattia di alzheimer.
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
AU2006237346B2 (en) * 2005-04-20 2011-04-07 Basf Plant Science Gmbh Expression cassettes for seed-preferential expression in plants
WO2009114939A1 (en) 2008-03-17 2009-09-24 National Research Council Of Canada Aromatic prenyltransferase from hop

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
JPH0770235B2 (ja) * 1988-06-24 1995-07-31 株式会社東芝 不揮発性メモリ回路装置
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体

Also Published As

Publication number Publication date
CZ12297A3 (cs) 1998-04-15
JPH10502652A (ja) 1998-03-10
ZA955865B (en) 1997-01-14
MX9700439A (es) 1998-05-31
NO970185D0 (no) 1997-01-15
US5776911A (en) 1998-07-07
BG101145A (en) 1997-08-29
EP0771202A1 (de) 1997-05-07
HRP950405A2 (en) 1997-10-31
IL114540A0 (en) 1995-11-27
NO970185L (no) 1997-03-12
KR970704442A (ko) 1997-09-06
DE4425280A1 (de) 1996-01-18
PL318318A1 (en) 1997-06-09
FI970165A0 (fi) 1997-01-15
HU9700130D0 (en) 1997-02-28
AU2927195A (en) 1996-02-16
FI970165A (fi) 1997-03-14
WO1996002252A1 (de) 1996-02-01
HUT76834A (en) 1997-11-28
CA2195345A1 (en) 1996-02-01
DE4425280C2 (de) 1997-05-07

Similar Documents

Publication Publication Date Title
ZA200309632B (en) Medicinal composition for treatment of interstitial cystitis.
EP0610336B1 (de) Behandlung von neurologischen Zuständen durch eine Interleukin-i-inhibierende Verbindung
SI9520087A (en) USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
EP1669078A1 (de) Cerebrovaskuläre Regenerations-/Rekonstruktionspromotoren und Inhibitoren der sekundären Degeneration von neuronalem Gewebe enthaltend Ginsenosid RB 1
Cadichon et al. Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats
ES2235896T3 (es) Uso de riluzol para el tratamaiento de la esclerosis multiple.
US5872124A (en) Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite
US6004986A (en) Method for treating cerebral vasospasm and cerebral ischemia using iron chelators and pharmaceutical compositions therefor
US20060287353A1 (en) Method for preventing or treating ischemia-or hemorrhage-induced brain damage using a macrolide compound
EP0904782A1 (de) Heilung von wirbelsäulenverletzungen
US9504666B2 (en) Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
JPH06263636A (ja) 脳または高次神経疾患治療剤
Kitamura et al. Menstrual stage influences postoperative nausea and vomiting following epidural buprenorphine
MXPA97000439A (en) Use of (s) -adenosil-l-metionine (same) and its salesphisiologically compatible for treatment of reperfusion damage activated by focal tempo ischemia
Harukuni et al. Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats
Watkins et al. E-Aminocaproic acid in traumatic hyphema.
KR20170003530A (ko) 외상후 스트레스 장애(ptsd) 및 안면 홍조를 치료하기 위한 키트 및 방법
AU2004206161B2 (en) Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
DE60225576T2 (de) Verfahren zur unterdrückung der bildung von seromen mit faktor xiii
JPH04330011A (ja) 末梢動脈閉塞症改善剤
George A Comparative Study of Hemodynamic Effects of Induction Doses of Propofol-Thiopentone and Propofol-Ketamine Combinations
RAJKUMAR et al. AP HALL
HRP960196A2 (en) NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
WO2001097812A1 (fr) Preparations pharmaceutiques contenant des composes tetracycliques
CN1156408A (zh) (S)-腺苷基-L-甲硫氨酸(SAMe)及其生理上耐受的盐治疗暂时局部缺血病灶引起的再灌注损伤的用途